Fachliteratur Gastroenterologie: Neoplasien Oesophagus

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Oesophagus » Neoplasie

07. September 2026

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 1982


	Artikel 1 - 20 / 39631

	Prognostic significance of DNA damage response-related markers in esophageal squamous cell carcinoma using machine learning approaches. J Gastrointest Oncol Huang C, Zhang YJ, Zhang F, Gai CY, Li ZH, Lv HL, Wen SW, Tian ZQ. PMID: 42703410 [PubMed]
	Nodal status and advanced clinical stage as determinants of response and survival after induction chemoradiotherapy in esophageal and gastroesophageal junction cancer: a single-centre retrospective cohort study. J Gastrointest Oncol Schaefer S, Kanjeekal S, Elfiki T, Mathews J, Ghafoor A, Nasser A. PMID: 42703407 [PubMed]
	The association between coffee consumption and esophageal cancer risk: a systematic review and meta-analysis of current observational evidence. J Gastrointest Oncol Zhao Y, Cai Z, Zhang J. PMID: 42703284 [PubMed]
	First-Line PD-1 Inhibitor-Based Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma: A Revised Systematic Review and Meta-Analysis of Phase III Trials. Cancer Rep (Hoboken) Rothweiler V, Roderburg C, Koeksal M, Jensen BEO, Feldt T, Gencer I, Fischer JC, Budach W, Knoefel WT, Lu G, Bölke E. PMID: 42702772 [PubMed - indexed for MEDLINE]
	Risks of adverse respiratory outcomes in adults with cancer over the course of survivorship compared with cancer-free individuals: a matched cohort study using linked English electronic health records. EClinicalMedicine Andresen K, Carreira H, Forbes H, Bowen L, Quint JK, Williamson E, Bhaskaran K. PMID: 42701415 [PubMed]
	Antibody-Drug Conjugates in the Treatment of Esophageal Cancer. Curr Treat Options Oncol Wu D, Chen W, Zhao Q, Zhu W, Xu J. PMID: 42700288 [PubMed - indexed for MEDLINE]
	Efficacy and Safety of DVDMS-Photodynamic Therapy for Dysphagia in Advanced Esophageal Cancer: A Phase II Clinical Trial. Cancer Sci Zhou J, Gao S, Yuan J, Chen H, Shu Y, Fan H, Cao Y, Shan T, Dong C, Zhang H, Song Q, Xin B, Zhang H, Lu Z, Shen L. PMID: 42700165 [PubMed - as supplied by publisher]
	QResearch primary care records linked to national hospital and cancer registry data: a validation study. ESMO Real World Data Digit Oncol Kulkarni S, Perletta V, Wang Z, Tomlinson JW, Hippisley-Cox J, Collins GS, Clift AK, Dodwell D, Lord SR. PMID: 42699058 [PubMed]
	Correction: Robotic Versus Laparoscopic Gastrectomy for Advanced Gastric Cancer: Prognostic Implications of Surgical Recovery and Oncologic Control in a Propensity Score-Matched Study. Ann Surg Oncol Komatsu S, Konishi T, Ohashi T, Nagamori H, Ogawa S, Matsumoto Y, Fujita Y, Matsuo H, Kuriu Y, Ikoma H, Okamoto K, Otsuji E, Shiozaki A. PMID: 42698012 [PubMed - as supplied by publisher]
	Spectral CT-based Nomogram for Noninvasive Assessment and Prognostic Prediction of MSI/dMMR in Esophagogastric Junction Adenocarcinoma. Radiol Imaging Cancer Wu Y, Lin K, Lin N, Lin Y, Huang X, Wang M, She D, Cao D. PMID: 42695789 [PubMed - indexed for MEDLINE]
	Goal-directed nutritional support in preserving muscle mass and optimising recovery in treatment of oesophageal cancer: results of a prospective non-randomised cluster trial. Support Care Cancer Barth I, Stelwagen I, Weerink LBM, Dijk DG, Meinders H, Milovanovic M, Haveman JW, van Det MJ, Dijkstra G, Campmans-Kuijpers MJE. PMID: 42693322 [PubMed - indexed for MEDLINE]
	Prevalence of Claudin 18.2 Expression in Gastric and Gastroesophageal Junction Adenocarcinoma: A Systematic Review and Meta-Analysis. J Gastrointest Cancer Khan FE, Majumdar R, Dodeja M, Alves GAM, Harby A, Siddiqui R, Madappattuparambil S. PMID: 42690279 [PubMed - indexed for MEDLINE]
	Sodium-glucose cotransporter-2 inhibitors and gastrointestinal neoplasm risk in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Clin Exp Med Zhang YF, Xie JJ, Wu Q, Zhou XY, Zeng C, Zeng Y, He YM, Guo M, Teng FY, Xu Y. PMID: 42690254 [PubMed - indexed for MEDLINE]
	A real-world multicenter study on postoperative adjuvant treatment patterns and prognostic implications following neoadjuvant immunochemotherapy for esophageal squamous cell carcinoma. Front Immunol Zhang X, Gao H, Cao J, Gao M, Xu Y, Zhang W, Qian P, Liu X, Fu Z, Shen W. PMID: 42688471 [PubMed - indexed for MEDLINE]
	The efficacy and safety of pembrolizumab in the treatment of HER2-negative advanced gastric or gastroesophageal junction cancer: a systematic review and meta-analysis of emerging clinical data. Front Immunol Yang Y, Jiang L, Zhang G, Li K, Li D. PMID: 42688407 [PubMed - indexed for MEDLINE]
	The role of circulating tumor DNA (ctDNA) to detect minimal residual disease in locally advanced gastroesophageal carcinoma: the BUTTERFLY study. ESMO Gastrointest Oncol Puccini A, Paracchini L, Alfieri R, Ancona L, Daprà V, Migliaccio G, Cammarota A, Mannarino L, Bartolini M, Miele V, Airaghi C, Beltrame L, Rella A, Mella G, Piemontese M, Pansa A, Garbarino GM, Basato S, Capogreco A, Franceschini D, D'Orazio F, Fraticelli S, Pistillo D, Spaggiari P, Laghi A, Hassan C, Scorsetti M, Repici A, Janjigian YY, Castoro C, Santoro A, Marchini S. PMID: 42688382 [PubMed]
	Precision Oncology in Gastrointestinal and Colorectal Cancer Surgery. Hematol Oncol Clin North Am McDonald HG, Kerekes DM, Kim J, Khan SA. PMID: 42686330 [PubMed - indexed for MEDLINE]
	Oncological outcomes and recurrence patterns after robot-assisted versus video-assisted esophagectomy for cT3br/cT4b esophageal cancer. Dis Esophagus Abe T, Higaki E, Hosoi T, Inada K, Ozaki K, An B, Yamaguchi J, Komori K, Ito S. PMID: 42685263 [PubMed - indexed for MEDLINE]
	Neoadjuvant immunochemotherapy with or without radiotherapy for locally advanced esophageal squamous cell carcinoma: a pooled analysis of two prospective single-arm clinical trials. Int J Surg Li Y, Jiang M, Zhu Z, Xu Y, Jiang F, Feng D, Cao G, Song X, Zhao L, Kong C, Wu Y, Gu L, Huang X, Guo Z, Zhang J, Yang B, Xiao G, Zhao Y, Ye J, Jiang N, Zhu X. PMID: 42682320 [PubMed]
	Beyond Zolbetuximab: Next-Generation Targeting Strategies for CLDN18.2. J Gastrointest Cancer Sagawa T, Nagashima H, Fujikawa K. PMID: 42681308 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 39631

Seite 1 von 1982



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung